8,023
Views
266
CrossRef citations to date
0
Altmetric
Review Article

Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A

, , , , , , , & show all
Pages 263-291 | Received 05 Nov 2010, Accepted 25 Jan 2011, Published online: 26 Mar 2011

References

  • Abad MC, Askari H, O’Neill J, Klinger AL, Milligan C, Lewandowski F, Springer B, Spurlino J, Rentzeperis D. (2008). Structural determination of estrogen-related receptor gamma in the presence of phenol derivative compounds. J Steroid Biochem Mol Biol 108:44–54.
  • Akingbemi BT, Sottas CM, Koulova AI, Klinefelter GR, Hardy MP. (2004). Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology 145:592–603.
  • Allegaert K, Vanhole C, Vermeersch S, Rayyan M, Verbesselt R, de Hoon J. (2008). Both postnatal and postmenstrual age contribute to the interindividual variability in tramadol glucuronidation in neonates. Early Hum Dev 84:325–330.
  • Anderson GD. (2005). Pregnancy-induced changes in pharmacokinetics: A mechanistic-based approach. Clin Pharmacokin 44:989–1008.
  • Angerer J, Ewers U, Wilhelm M. (2007). Human biomonitoring: State of the art. Int J Hyg Environ Health 210:201–228.
  • Aschberger K, Castello P, Hoekstra E, Karakitsios S, Munn S, Pakalin S, Sarigiannis D (2010). Bisphenol A and baby bottles: Challenges and perspectives. JRC Scientific and Technical Reports, European Union.
  • Ashby J, Odum J. (2004). Gene expression changes in the immature rat uterus: Effects of uterotrophic and sub-uterotrophic doses of bisphenol A. Toxicol Sci 82:458–467.
  • Ashby J, Tinwell H, Haseman J. (1999). Lack of effects for low dose levels of bisphenol A and diethylstilbestrol on the prostate gland of CF1 mice exposed in utero. Regul Toxicol Pharmacol 30:156–166.
  • Balakrishnan B, Henare K, Thorstensen EB, Ponnampalam AP, Mitchell MD. (2010). Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol 202:393.e1–e7.
  • Bolt HM, Janning P, Michna H, Degen GH. (2001). Comparative assessment of endocrine modulators with oestrogenic activity: I. Definition of a hygiene-based margin of safety (HBMOS) for xeno-oestrogens against the background of European developments. Arch Toxicol 74:649–662.
  • Bondesson M, Jönsson J, Pongratz I, Olea N, Cravedi JP, Zalko D, Håkansson H, Halldin K, Di Lorenzo D, Behl C, Manthey D, Balaguer P, Demeneix B, Fini JB, Laudet V, Gustafsson JA. (2009). A CASCADE of effects of bisphenol A. Reprod Toxicol 28:563–567.
  • Boogaard PJ. (2007). Human biomonitoring activities—Programmes by industry. Int J Hyg Environ Health 210:259–261.
  • Borrell B. (2010). Toxicology: The big test for bisphenol A. Nature 464:1122–1124.
  • Brede C, Fjeldal P, Skjevrak I, Herikstad H. (2003). Increased migration levels of bisphenol A from polycarbonate baby bottles after dishwashing, boiling and brushing. Food Addit Contam 20:684–689.
  • Bushnik T, Haines D, Levallois P, Levesque J, Van Oostdam J, Viau C. (2010). Lead and bisphenol A concentrations in the Canadian population. Health Reports, Component of Statistics Canada (82-003-X) 21:1–12.
  • Butler JM, Begg EJ.(2008) Free drug metabolic clearance in elderly people. Clin Pharmacokinet 47:297–321.
  • Cagen SZ, Waechter JM Jr, Dimond SS, Breslin WJ, Butala JH, Jekat FW, Joiner RL, Shiotsuka RN, Veenstra GE, Harris LR. (1999). Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A. Toxicol Sci 50:36–44.
  • Calafat AM, Needham LL. (2007). Factors affecting the evaluation of biomonitoring data for human exposure assessment. Int J Androl 30:1–5.
  • Calafat AM, Needham LL. (2009). What additional factors beyond state-of-the-art analytical methods are needed for optimal generation and interpretation of biomonitoring data? Environ Health Perspect 117:1481–1485.
  • Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. (2005). Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113:391–395.
  • Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. (2008). Exposure of the U.S. population to bisphenol A and 4–tertiary-octylphenol: 2003–2004. Environ Health Perspect 116:39–44.
  • Calafat AM, Weuve J, Ye X, Jia LT, Hu H, Ringer S, Huttner K, Hauser R. (2009). Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect 117:639–644.
  • Campbell NR, Van Loon JA, Sundaram RS, Ames MM, Hansch C, Weinshilboum R. (1987a). Human and rat liver phenol sulfotransferase: Structure-activity relationships for phenolic substrates. Mol Pharmacol 32:813–819.
  • Campbell NR, Van Loon JA, Weinshilboum RM. (1987b). Human liver phenol sulfotransferase: Assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Biochem Pharmacol 36:1435–1446.
  • Canada Gazette. Part II, March 31, 2010.
  • Cao XL, Corriveau J. (2008). Migration of bisphenol A from polycarbonate baby and water bottles into water under severe conditions. J Agric Food Chem 56:6378–6381.
  • Cao XL, Corriveau J, Popovic S, Coughlan MC, Chepelev N, Willmore W, Schrader T, Jin X. (2010). Background bisphenol A in experimental materials and its implication to low-dose in vitro study. Chemosphere 81:817–820.
  • Chapin RE, Adams J, Boekelheide K, Gray LE Jr, Hayward SW, Lees PS, McIntyre BS, Portier KM, Schnorr TM, Selevan SG, Vandenbergh JG, Woskie SR. (2008). NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res B Dev Reprod Toxicol 83:157–395.
  • Cho CY, Shin BS, Jung JH, Kim DH, Lee KC, Han SY, Kim HS, Lee BM, Yoo SD. (2002). Pharmacokinetic scaling of Bisphenol A by species-invariant time methods. Xenobiotica 32:925–934.
  • Coughtrie MWH. (2002). Sulfation through the looking glass—Recent advances in sulfotransferase research for the curious. Pharmacogenom J 2:297–308.
  • Court MH. (2010). Interindividual variability in hepatic drug glucuronidation: Studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev 42:202–217.
  • Danish Ministry of Food, Agriculture and Fisheries (2010). Danish ban on bisphenol A in materials in contact with food for children aged 0–3. Available at: http://www.fvm.dk/Default.aspx?ID=18488&PID=169747&NewsID=6014. March 2010.
  • Dekant W, Völkel W. (2008). Human exposure to bisphenol A by biomonitoring: Methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 228:114–134.
  • Dodds EC, Lawson W. (1936). Synthetic oestrogenic agents without the phenanthrene nucleus. Nature 137:996.
  • Doerge DR, Twaddle NC, Vanlandingham M, Fisher JW. (2010a). Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats. Toxicol Appl Pharmacol 247:158–165.
  • Doerge DR, Twaddle NC, Woodling KA, Fisher JW. (2010b). Pharmacokinetics of bisphenol a in neonatal and adult rhesus monkeys. Toxicol Appl Pharmacol 248:1–11.
  • Duanmu Z, Weckle A, Koukouritaki SB, Hines RN, Falany JL, Falany CN, Kocarek TA, Runge-Morris M. (2006). Developmental expression of ary, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J Pharmacol Exp Ther 316:1310–1317.
  • Edginton AN, Ritter L. (2009). Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic model. Environ Health Perspect 117:645–652.
  • Edginton AN, Schmitt W, Voith B, Willmann S. (2006). A mechanistic approach for the scaling of clearance in children. Clin Pharmacokinet 45:683–704.
  • EFSA (European Food Safety Authority). (2006). Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) related to 2,2-bis(4hydroxyphenyl)propane. EFSA J 428:1–75.
  • EFSA (European Food Safety Authority). (2007). Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to 2,2-BIS(4-HYDROXYPHENYL)PROPANE. January 2007. Available at: http://www.efsa.europa.eu/en/scdocs/scdoc/428.htm.
  • EFSA (European Food Safety Authority). (2008). Toxicokinetics of Bisphenol A—Scientific Opinion of the Panel on Food additives, Flavourings, Processing aids and Materials in Contact with Food (AFC). Available at: http://www.efsa.europa.eu/en/scdocs/scdoc/759.htm. July 2008.
  • EFSA (European Food Safety Authority). (2010a). Scientific Opinion on Bisphenol A: Evaluation of a study investigating its neurodevelopmental toxicity, review of recent scientific literature on its toxicity and advice on the Danish risk assessment of Bisphenol A of the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) on request from the European Commission, Questions No. EFSA-Q-2009-00864, EFSA-Q-2010-01023 and EFSA-Q-2010-00709, adopted on 23rd September 2010. EFSA J 8:1829, 1–116. Available at: http://www.efsa.europa.eu/en/scdocs/scdoc/1829.htm. (September 2010).
  • EFSA (European Food Safety Authority). (2010b). Statistical re-analysis of the Biel maze data of the Stump et al (2010) study: “Developmental neurotoxicity study of dietary bisphenol A in Sprague-Dawley rats”. Question No. EFSA-Q-2010-01142. Adopted: 30 September 2010. EFSA J 8:1836, 1–67. Available at: http://www.efsa.europa.eu/fr/efsajournal/pub/1836.htm. September 2010.
  • Elsby R, Maggs JL, Ashby J, Park BK. (2001a). Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: Implications for extrapolation to humans. J Pharmacol Exp Ther 297:103–113.
  • Elsby R, Maggs JL, Ashby J, Paton D, Sumpter JP, Park BK. (2001b). Assessment of the effects of metabolism on the estrogenic activity of xenoestrogens: A two-stage approach coupling human liver microsomes and a yeast estrogenicity assay. J Pharmacol Exp Ther 296:329–337.
  • Ema M, Fujii S, Furukawa M, Kiguchi M, Ikka T, Harazono A. (2001). Rat two-generation reproductive toxicity study of bisphenol A. Reprod Toxicol 15:505–523.
  • EU. (2003). European Union Risk Assessment Report. Bisphenol A, CAS No: 80-05-7. Institute for Health and Consumer Protection, European Chemicals Bureau, European Commission Joint Research Centre, 3rd Priority List. Luxembourg: Office for Official Publications of the European Communities.
  • EU. (2008). European Union Risk Assessment Report. Bisphenol A, CAS No: 80-05-7, Addendum 2008. Institute for Health and Consumer Protection, European Chemicals Bureau, European Commission Joint Research Centre, 3rd Priority List, Luxembourg: Office for Official Publications of the European Communities.
  • Federal Office of Public Health (FOPH). (2009). Factsheet Bisphenol A (in German). Available at: http://www.bag.admin.ch/themen/lebensmittel/04861/06170/index.html. (February 2009).
  • Fini JB, Dolo L, Cravedi JP, Demeneix B, Zalko D. (2009). Metabolism of the endocrine disruptor BPA by Xenopus laevis tadpoles. Ann N Y Acad Sci 1163:394–397.
  • Fukata H, Miyagawa H, Yamazaki N, Mori C. (2006). Comparison of ELISA- and LC-MS-based methodologies for the exposure assessment of bisphenol A. Toxicol Mech Methods 16:427–430.
  • Galloway T, Cipelli R, Guralnick J, Ferrucci L, Bandinelli S, Corsi AM, Money C, McCormack P, Melzer D. (2010). Daily Bisphenol A excretion and associations with sex hormone concentrations: Results from the InCHIANTI Adult Population Study. Environ Health Perspect 118:1603–1608.
  • Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL, McManus ME. (2006). Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 90:5–22.
  • García-Prieto A, Lunar ML, Rubio S, Pérez-Bendito D. (2008). Determination of urinary bisphenol A by coacervative microextraction and liquid chromatography-fluorescence detection. Anal Chim Acta 630:19–27.
  • Geens T, Apelbaum TZ, Goeyens L, Neels H, Covaci A. (2010). Intake of bisphenol A from canned beverages and foods on the Belgian market. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 27:1627–1637.
  • Gies A, Heinzow B, Dieter HH, Heindel J. (2009). Bisphenol A workshop of the German Federal Environment Agency—March 30–31, 2009 work group report: Public health issues of bisphenol A. Int J Hyg Environ Health 212:693–696.
  • Ginsberg G, Rice DC. (2009). Does rapid metabolism ensure negligible risk from bisphenol A? Environ Health Perspect 117:1639–1643.
  • Goodman JE, McConnell EE, Sipes IG, Witorsch RJ, Slayton TM, Yu CJ, Lewis AS, Rhomberg LR. (2006). An updated weight of the evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Crit Rev Toxicol 36:387–457.
  • Goodman JE, Witorsch RJ, McConnell EE, Sipes IG, Slayton TM, Yu CJ, Franz AM, Rhomberg LR. (2009). Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Crit Rev Toxicol 39:1–75.
  • Gow PJ, Ghabrial H, Smallwood RA, Morgan DJ, Ching MS. (2001). Neonatal hepatic drug elimination. Pharmacol Toxicol 88:3–15.
  • Gray GM, Cohen JT, Cunha G, Hughes C, McDonnell EE, Rhomberg L, Sipes IG, Mattison D. (2004). Weight of the evidence evaluation of low-dose reproductive and developmental effects of bisphenol A. Hum Ecol Risk Assess 10:875–921.
  • Gray LE Jr. (2008). Written testimony before the Committee on Energy and Commerce, Subcommittee on Commerce, Trade, and Consumer Protection, United States House of Representatives, June 10, 2008 (unpublished document).
  • Gray LE Jr, Ryan B, Hotchkiss AK, Crofton KM. (2010). Rebuttal of “Flawed experimental design revelas the need for guidelines requiring appropriate positive controls in endocrine disruption research” by Vom Saal 2010. Toxicol Sci 115:614–620.
  • Günzel P, Putz B, Lehmann M, Hasan SH, Hümpel M, El Etreby MF. (1989). Steroid toxicology and the “pill”: Comparative aspects of experimental test systems and the human. In: Dayan AD, Paine AJ, eds. Advances in Applied Toxicology. London: Taylor & Francis, 19–49.
  • Hanioka N, Naito T, Narimatsu S. (2008). Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Chemosphere 24:33–36.
  • He P, Court MH, Greenblatt DJ, von Moltke LL. (2006). Factors influencing midazolam hydroxylation activity in human liver microsomes. Drug Metab Dispos 34:1198–1207.
  • Health Canada. (2008). Health Risk Assessment of Bisphenol A from Food Packaging Applications. Published by Authority of the Minister of Health, Canada, August 2008. Available at: http://www.hc-sc.gc.ca/fn-an/securit/packag-emball/bpa/bpa_hra-ers-eng.php.
  • Health Canada. (2009a). Survey of bsphenol A in canned drink products. Bureau of Chemical Safety, Food Directorate, Health Products and Food Branch, March 2009.
  • Health Canada. (2009b). Survey of bisphenol A in bottled water products. Bureau of Chemical Safety, Food Directorate, Health Products and Food Branch. Available at: http://www.hc-sc.gc.ca/fn-an/alt_formats/hpfb-dgpsa/pdf/securit/bpa_survey-enquete-bot-bou-eng.pdf. (July 2009).
  • Health Canada. (2009c). Survey of bisphenol A in canned powdered infant formula products. Bureau of Chemical Safety, Food Directorate, Health Products and Food Branch. Available at: http://www.hc-sc.gc.ca/fn-an/alt_formats/hpfb-dgpsa/pdf/securit/bpa_survey-enquete-bot-bou-eng.pdf. (July 2009).
  • Health Canada. (2009d). Investigation of storage time on potential bisphenol A: Migration into canned liquid infant formula stored at room temperature. Bureau of Chemical Safety, Food Directorate, Health Products and Food Branch. (December 2009).
  • Helander A, Dahl H. (2005). Urinary tract infection: A risk factor for false-negative urinary ethyl glucuronide but not ethyl sulfate in the detection of recent alcohol consumption. Clin Chem 51:1728–1730.
  • Hengstler JG, Van der Burg B, Steinberg P, Oesch F. (1999). Interspecies differences in cancer susceptibility and toxicity. Drug Metab Rev 31:917–970.
  • Hewitt NJ, Lechón MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, Guillouzo A, Tuschl G, Li AP, LeCluyse E, Groothuis GM, Hengstler JG. (2007). Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39:159–234.
  • Ho YC, Ho KJ. (1985). Differential quantitation of urinary beta-glucuronidase of human and bacterial origins. J Urol 134:1227–1230.
  • Hodge LS, Tracy TS. (2007). Alterations in drug disposition during pregnancy: Implications for drug therapy Expert Opin Drug Metab Toxicol 3:557–571.
  • Hoppin JA, Ulmer R, Calafat AM, Barr DB, Baker SV, Meltzer HM, Ronningen KS. (2006). Impact of urine preservation methods and duration of storage on measured levels of environmental contaminants. J Expo Sci Environ Epidemiol 16:39–48.
  • Howdeshell KL, Furr J, Lambright CR, Wilson VS, Ryan BC, Gray LE Jr. (2008). Gestational and lactational exposure to ethinyl estradiol, but not bisphenol A, decreases androgen-dependent reproductive organ weights and epididymal sperm abundance in the male Long-Evans hooded rat. Toxicol Sci 102:371–382.
  • Huang WS, Kuo SW, Chen WL, Hsich KS, Wu SY. (1996). Maturation of hepatic desulfation activity in developing rats. J Formos Med Assoc 95:435–439.
  • Hunt PA, Susiarjo M, Rubio C, Hassold TJ. (2009). The bisphenol A experience: A primer for the analysis of environmental effects on mammalian reproduction. Biol Reprod 81:807–813.
  • Inoue H, Yokota H, Makino T, Yuasa A, Kato S. (2001). Bisphenol a glucuronide, a major metabolite in rat bile after liver perfusion. Drug Metab Dispos 29:1084–1087.
  • Inoue H, Yuki G, Yokota H, Kato S. (2003). Bisphenol A glucuronidation and absorption in rat intestine. Drug Metab Dispos 31:140–144.
  • International Commission on Radiological Protection. (2002). Basic anatomical and physiological data for use in radiological protection: Reference values. ICRP Publication 89. Amsterdam: Elsevier Science.
  • Iwamori M. (2005). Estrogen sulfatase. Methods Enzymol 400:293–302.
  • Kim YH, Kim CS, Park S, Han SY, Pyo MY, Yang M. (2003). Gender differences in the levels of bisphenol A metabolites in urine. Biochem Biophys Res Commun 312:441–448.
  • Klimisch HJ, Andreae E, Tillmann U. (1997). A systematic approach for evaluating the quality of experimental and ecotoxicological data. Regul Toxicol Pharmacol 25:1–5.
  • Kuhnz W, Blode H, Zimmermann H. (1999). Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens. In: Oettel M, Schillinger E, eds. Handbook of Experimental Pharmacology, Vol. 135/II Estrogens and Antiestrogens. Berlin, Heidelberg: Springer-Verlag, 279 (animal data), 282 (human data).
  • Kum H, Kim MK, Choi HT. (2009). Degradation of endocrine disrupting chemicals by genetic transformants in Irpex lacteus with an inducible laccase gene of Phlebia tremellosa. Biodegradatio 20:673–678.
  • Kurebayashi H, Harada R, Stewart RK, Numata H, Ohno Y. (2002). Disposition of a low dose of bisphenol A in male and female cynomolgus monkeys. Toxicol Sci 68:32–42.
  • Kurebayashi H, Betsui H, Ohno Y. (2003). Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide. Toxicol Sci 73:17–25.
  • Kurebayashi H, Okudaira K, Ohno Y (2010). Species difference of metabolic clearance of bisphenol A using cryopreserved hepatocytes from rats, monkeys and humans. Toxicol Lett 198:210–215.
  • Lakind JS, Naiman DQ. (2008). Bisphenol A (BPA) daily intakes in the United States: Estimates from the 2003–2004 NHANES urinary BPA data. J Expo Sci Environ Epidemiol 18:608–615.
  • Lakind JS, Naiman DQ. (2010). Daily intake of bisphenol A and potential sources of exposure: 2005–2006 National Health and Nutrition Examination Survey. J Expo Sci Environ Epidemiol advance online publication 17 Mar 2010; doi:10.1038/jes.2010.9
  • Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, Melzer D (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303–1310.
  • Lee YJ, Ryu HY, Kim HK, Min CS, Lee JH, Kim E, Nam BH, Park JH, Jung JY, Jang DD, Park EY, Lee KH, Ma JY, Won HS, Im MW, Leem JH, Hong YC, Yoon HS. (2008). Maternal and fetal exposure to bisphenol A in Korea. Reprod Toxicol 25:413–419.
  • Liu X, Matsushima A, Okada H, Shimohigashi Y. (2010). Distinction of the binding modes for human nuclear receptor ERRgamma between bisphenol A and 4-hydroxytamoxifen. J Biochem 148:247–254.
  • Lorentzen R, Hattan D. (2010). Response to Nature Editorial. Nature 464:1103–1104. Available at: http://www.nature.com/nature/journal/v464/n7292/full/4641103b.html.
  • Mao L, Sun C, Zhang H, Li Y, Wu D. (2004). Determination of environmental estrogens in human urine by high performance liquid chromatography after fluorescent derivatization with p-nitrobenzoyl chloride. Anal Chim Acta 522:241–246.
  • Markham DA, Waechter JM Jr, Wimber M, Rao N, Connolly P, Chuang JC, Hentges S, Shiotsuka RN, Dimond S, Chappelle AH. (2010). Development of a method for the determination of bisphenol A at trace concentrations in human blood and urine and elucidation of factors influencing method accuracy and sensitivity. J Anal Toxicol 34:293–303.
  • Matsushima A, Kakuta Y, Teramoto T, Koshiba T, Liu X, Okada H, Tokunaga T, Kawabata S, Kimura M, Shimohigashi Y. (2007). Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma. J Biochem 142:517–524.
  • Matthews JB, Twomey K, Zacharewski TR. (2001). In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide with estrogen receptors α and β. Chem Res Toxicol 14:149–157.
  • Mazur Ch S, Kenneke JF, Hess-Wilson JK, Lipscomb JC. (2010). Differences between human and rat intestinal and hepatic bisphenol-A glucuronidation and the influence of alamethicin on in vitro kinetic measurements. DMD Fast Forward. Published on August 24, 2010 at doi:10.1124/dmd.110.034819. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20736320.
  • Meeker JD, Calafat AM, Hauser R. (2010a). Urinary bisphenol A concentrations in relation to serum thyroid and reproductive hormone levels in men from an infertility clinic. Environ Sci Technol 4:1458–1463.
  • Meeker JD, Ehrlich S, Toth TL, Wright DL, Calafat AM, Trisini AT, Ye X, Hauser R. (2010b). Semen quality and sperm DNA damage in relation to urinary bisphenol A among men from an infertility clinic. Reprod Toxicol 30:532–539.
  • Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. (2010). Association of urinary bisphenol a concentration with heart disease: Evidence from NHANES 2003/06. PloS One 5:e8673.
  • Mielke H, Gundert-Remy U. (2009). Bisphenol A levels in blood depend on age and exposure. Toxicol Lett 190:32–40.
  • Miki Y, Nakata T, Suzuki T, Darnel AD, Moriya T, Kaneko C, Hidaka K, Shiotsu Y, Kusaka H, Sasano H. (2002). Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues. J Clin Endocrinol Metab 87:5760–5768.
  • Miyagi SJ, Collier AC. (2007). Pediatric development of glucuronidation: The ontogeny of hepatic UGT1A4. Drug Metab Dispos 35:1587–1592.
  • Miyakawa H, Shimamura Y, Suzuki K, Ibe A, Saito K. (2004). Determination of bisphenol A in total diet study samples by GC/MS. Annual Report of the Tokyo Metropolitan Institute of Public Health, Vol. 55.
  • Miyamoto K, Kotake M. (2006). Estimation of daily bisphenol A intake of Japanese individuals with emphasis on uncertainty and variability. Environ Sci 13:15–29.
  • Mnif W, Pascussi JM, Pillon A, Escande A, Bartegi A, Nicolas JC, Cavaillès V, Duchesne MJ, Balaguer P. (2007). Estrogens and antiestrogens activate hPXR. Toxicol Lett 170:19–29.
  • Moors S, Blaszkewicz M, Bolt HM, Degen GH. (2007). Simultaneous determination of daidzein, equol, genistein and bisphenol A in human urine by a fast and simple method using SPE and GC-MS. Mol Nutr Food Res 51:787–798.
  • Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, Hataya Y, Shimatsu A, Kuzuya H, Nakao K. (2002). Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 87:5185–5190.
  • Myers JP, vom Saal FS, Akingbemi BT, Arizono K, Belcher S, Colborn T, Chahoud I, Crain DA, Farabollini F, Guillette LJ Jr, Hassold T, Ho SM, Hunt PA, Iguchi T, Jobling S, Kanno J, Laufer H, Marcus M, McLachlan JA, Nadal A, Oehlmann J, Olea N, Palanza P, Parmigiani S, Rubin BS, Schoenfelder G, Sonnenschein C, Soto AM, Talsness CE, Taylor JA, Vandenberg LN, Vandenbergh JG, Vogel S, Watson CS, Welshons WV, Zoeller RT. (2009). Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: The case of bisphenol A. Environ Health Perspect 117:309–315.
  • Naciff JM, Hess KA, Overmann GJ, Torontali SM, Carr GJ, Tiesman JP, Foertsch LM, Richardson BD, Martinez JE, Daston GP. (2005). Gene expression changes induced in the testis by transplacental exposure to high and low doses of 17{alpha}-ethynyl estradiol, genistein, or bisphenol A. Toxicol Sci 86:396–416.
  • Naciff JM, Khambatta ZS, Reichling TD, Carr GJ, Tiesman JP, Singleton DW, Khan SA, Daston GP. (2010). The genomic response of Ishikawa cells to bisphenol A exposure is dose- and time-dependent. Toxicology 270:137–149.
  • Nagel SC, vom Saal FS, Thayer KA, Dhar MG, Boechler M, Welshons WV. (1997). Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect 105:70–76.
  • National Food Institute at the Technical University of Denmark (DTU Food). (2010). DTU Fødevareinstituttets vurdering af industriens nye developmental neurotoxicity studie (DNT, OECD TG 426) med bisphenol A og studiets betydning for Fødevareinstituttets vurdering af bisphenol A’s eventuelle skadelige effekter på udvikling af nervesystem og adfærd. 22 March 2010. Available at: http://www.food.dtu.dk/Default.aspx?ID = 8590.
  • Needham LL, Calafat AM, Barr DB. (2007). Uses and issues of biomonitoring. Int J Hyg Environ Health 210:229–238.
  • New Energy and Industrial Technology Development Organization (NEDO), the Research Center for Chemical Risk Management (CRM), and the National Institute of Advanced Industrial Science and Technology (AIST). (2007). Bisphenol A Risk Assessment Document (AIST Risk Assessment Document Series No. 4). November 2007. Available at: http://unit.aist.go.jp/riss/crm/mainmenu/BPA_Summary_English.pdf.
  • Newbold RR, Jefferson WN, Padilla-Banks E. (2009). Prenatal exposure to bisphenol A at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect 117:879–885.
  • Nishikawa M, Iwano H, Yanagisawa R, Koike N, Inoue H, Yokota H. (2010). Placental transfer of conjugated bisphenol A and subsequent reactivation in the rat fetus. Environ Health Perspect. 2010 Sep; 118(9):1196–203 epub 2010 Apr 9.
  • Nishiyama T, Ogura K, Nakano H, Kaku T, Takahashi E, Ohkubo Y, Sekine K, Hiratsuka A, Kadota S, Watabe T. (2002). Sulfation of environmental estrogens by cytosolic sulfotransferases. Drug Metab Pharmacokinet 17:221–228.
  • NTP (National Toxicology Program). (1982). NTP Technical Report on the carcinogenesis bioassay of bisphenol A (CAS No. 80-05-7) in F344 rats and B6C3F1 mice (feed study). Research Triangle Park, NC: NTP, NIEHS. NTP-80-35. NIH Publication No. 82-1771.
  • NTP (National Toxicology Program). (1985). Teratologic evaluation of bisphenol A (CAS No. 80-05-7) administered to CD-1 mice on gestational days 6–15. Research Triangle Park, NC: NTP, NIEHS.
  • NTP (National Toxicology Program). (1986). Teratologic evaluation of bisphenol A (CAS No. 80-05-7) administered to CD(R) rats on gestational days 6–15. Research Triangle Park, NC: NTP, NIEHS.
  • NTP (National Toxicology Program). (2008). NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Bisphenol A. NTP CERHR Monogr 2008(22):i–III1. NIH publication No. 08-5994.
  • NTP-CERHR. (2007). Expert Panel Report on the Reproductive and Developmental Toxicity of Bisphenol A. Research Triangle Park, NC: National Toxicology Program.
  • Okada H, Tokunaga T, Liu X, Takayanagi S, Matsushima A, Shimohigashi Y. (2008). Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ Health Perspect 116:32–38.
  • Pacifici GM, Kubrich M, Giuliani L, de Vries M, Rane A. 1993. Sulphation and glucuronidation of ritodrine in human foetal and adult tissues. Eur J Clin Pharmacol 44:259–264.
  • Padmanabhan V, Siefert K, Ransom S, Johnson T, Pinkerton J, Anderson L, Tao L, Kannan K. (2008). Maternal bisphenol-A levels at delivery: A looming problem? J Perinatol 28:258–263.
  • Paigen K, Peterson J. (1978). Coordinacy of lysosomal enzyme excretion in human urine. J Clin Invest 61:751–762.
  • Pottenger LH, Domoradzki JY, Markham DA, Hansen SC, Cagen SZ, Waechter JM Jr. (2000). The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci 54:3–18.
  • Papaconstantinou AD, Fisher BR, Umbreit TH, Brown KM. (2002). Increases in mouse uterine heat shock protein levels are a sensitive and specific response to uterotrophic agents. Environ Health Perspect110:1207–1212.
  • Ryan BC, Hotchkiss AK, Crofton KM, Gray LE Jr. (2010a). In utero and lactational exposure to bisphenol A, in contrast to ethinyl estradiol, does not alter sexually dimorphic behavior, puberty, fertility, and anatomy of female LE rats. Toxicol Sci 114:133–148.
  • Ryan KK, Haller AM, Sorrell JE, Woods SC, Jandacek RJ, Seeley RJ. (2010b). Perinatal exposure to bisphenol-A and the development of metabolic syndrome in CD-1 mice. Endocrinology 151:2603–2612.
  • Safe SH. (2000). Endocrine disruptors and human health—Is there a problem? An update. Environ Health Perspect 108:487–493.
  • Safe S. (2004). Endocrine disruptors and human health: Is there a problem? Toxicology 205:3–10.
  • Sajiki J, Takahashi K, Yonekubo J. (1999). Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 736:255–261.
  • Salas SP, Marshall G, Gutiérrez BL, Rosso P. (2006). Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 47:203–208.
  • Schönfelder G, Flick B, Mayr E, Talsness C, Paul M, Chahoud I. (2002a). In utero exposure to low doses of bisphenol A lead to long-term deleterious effects in the vagina. Neoplasia 2002;4:98–102.
  • Schönfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. (2002b). Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 110:A703–A707
  • Sharpe RM. (2010). Is it time to end concerns over the estrogenic effects of bisphenol A? Toxicol Sci 114:1–4.
  • Shin BS, Kim CH, Jun SY, Kim DW, Lee BM, Yoon CH, Park EH, Lee KC, Han S-Y, Park KL, Kim HS, Yoo SD. (2004). Physiologically based pharmacokinetics of bisphenol A. J Toxicol Environ Health A 67:1971–1985.
  • Snyder RW, Maness SC, Gaido KW, Welsch F, Sumner SCJ, Fennell TR. (2000). Metabolism and disposition of bisphenol A in female rats. Toxicol Appl Pharmacol 168:225–234.
  • Somm E, Schwitzgebel VM, Toulotte A, Cederroth CR, Combescure C, Nef S, Aubert ML, Hüppi PS. (2009). Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect 117:1549–1555.
  • Spivey A. (2009). Research issues and initiatives: NIEHS funds human BPA research. Environ Health Perspect 117:A541.
  • Stahlhut RW, Welshons WV, Swan SH. Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ Health Perspect. 2009;117:784–789.
  • Stanley EL, Hume R, Coughtrie MW. (2005). Expression profiling of human fetal cytosolic sulfotransferases involved in steroid and thyroid hormone metabolism and in detoxification. Mol Cell Endocrinol 240:32–42.
  • Stowell CL, Barvian KK, Young PC, Bigsby RM, Verdugo DE, Bertozzi CR, Widlanski TS. (2006). A role for sulfation-desulfation in the uptake of bisphenol a into breast tumor cells. Chem Biol 13:891–897.
  • Stump DG, Beck MJ, Radovsky A, Garman RH, Freshwater LL, Sheets LP, Marty MS, Waechter JM Jr, Dimond SS, Van Miller JP, Shiotsuka RN, Beyer D, Chappelle AH, Hentges SG. (2010). Developmental neurotoxicity study of dietary bisphenol A in Sprague-Dawley rats. Toxicol Sci 115:167–182.
  • Suiko M, Sakakibara Y, Liu MC. (2000). Sulfation of environmental estrogen-like chemicals by human cytosolic sulfotransferases. Biochem Biophys Res Commun 267:80–84.
  • Takeuchi T, Tsutsumi O. (2002). Serum bisphenola concentrations showed gender differens, possibly linked to androgen levels. Biochem Biophys Res Commun 291:76–78.
  • Tan E, Pang KS. (2001). Sulfation is rate limiting in the futile cycling between estrone and estrone sulphate in enriched periportal and perivenous rat hepatocytes. Drug Metab Dispos 29:335–346.
  • Tan BL, Mustafa AM. (2003). Leaching of bisphenol A from new and old babies’ bottles, and new babies’ feeding teats. Asia Pac J Public Health 15:118–123.
  • Taylor JA, vom Saal FS, Welshons WV, Drury B, Rottinghaus G, Hunt PA, VandeVoort CA. (2010). Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: Relevance for human exposure. Environ Health Perspect [Online]. Accessed 20 September 2010. [Epub ahead of print].
  • Teeguarden JG, Waechter JM Jr, Clewell HJ 3rd, Covington TR, Barton HA. (2005). Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Toxicol Sci 85:823–838.
  • Thomson BM, Grounds PR. (2005). Bisphenol A in canned foods in New Zealand: An exposure assessment. Food Addit Contam 22:65–72.
  • Timms BG, Howdeshell KL, Barton L, Bradley S, Richter CA, Vom Saal FS. (2005). Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci U S A 102:7014–7019.
  • Tinwell H, Haseman J, Lefevre PA, Wallis N, Ashby J. (2002). Normal sexual development of two strains of rat exposed in utero to low doses of bisphenol A. Toxicol Sci 68:339–348.
  • Tominaga T, Negishi T, Hirooka H, Miyachi A, Inoue A, Hayasaka I, Yoshikawa Y. (2006). Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC-MS/MS method. Toxicology 226:208–217.
  • Tsukioka T, Brock J, Graiser S, Nguyen J, Nakazawa H, Makino T. (2003). Determination of trace amounts of bisphenol A in urine by negative-ion chemical-ionization-gas chromatography/mass spectrometry. Anal Sci 19:151–153.
  • Tsukioka T, Terasawa J, Sato S, Hatayama Y, Makino T, Nakazawa H. (2004). Development of analytical method for determining trace amounts of BPA in urine samples and estimation of exposure to BPA. J Environ Chem 14:57–63.
  • Twaddle NC, Churchwell MI, Vanlandingham M, Doerge DR. (2010). Quantification of deuterated bisphenol A in serum, tissues, and excreta from adult Sprague-Dawley rats using liquid chromatography with tandem mass spectrometry. Rapid Commun Mass Spectrom 24:3011–3020.
  • Tyl RW. (2003). Bisphenol A: Findings of a multigenerational rat study. Environ Health Perspect 111:A632.
  • Tyl RW. (2009a). Basic exploratory research versus guideline-compliant studies used for hazard evaluation and risk assessment: Bisphenol A as a case study. Environ Health Perspect 117:1644–1651.
  • Tyl RW (2009b). The presence (or not) of effects from low oral doses of BPA. J Toxicol Sci 34:587–588.
  • Tyl RW, Myers CB, Marr MC, Thomas BF, Keimowitz AR, Brine DR, Veselica MM, Fail PA, Chang TY, Seely JC, Joiner RL, Butala JH, Dimond SS, Cagen SZ, Shiotsuka RN, Stropp GD, Waechter JM. (2002). Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol Sci 68:121–146.
  • Tyl RW, Myers CB, Marr MC, Fail PA, Seely JC, Elswick B, James A, Welsch F. (2003). Two-generation reproductive toxicity study of inhaled tertiary amyl methyl ether (TAME) vapor in CD rats. J Appl Toxicol 23:397–410.
  • Tyl RW, Myers CB, Marr MC, Castillo NP, Veselica MM, Joiner RL, Dimond SS, Van Miller JP, Stropp GD, Waechter JM Jr, Hentges SG. (2008a). One-generation reproductive toxicity study of dietary 17beta-estradiol (E2; CAS No. 50-28-2) in CD-1 (Swiss) mice. Reprod Toxicol 25:144–160.
  • Tyl RW, Myers CB, Marr MC, Sloan CS, Castillo NP, Veselica MM, Seely JC, Dimond SS, Van Miller JP, Shiotsuka RN, Beyer D, Hentges SG, Waechter JM Jr. (2008b). Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicol Sci 104:362–384.
  • Tyl RW, Myers CB, Marr MC, Sloan CS, Castillo NP, Veselica MM, Seely JC, Dimond SS, Van Miller JP, Shiotsuka RS, Stropp GD, Waechter JM Jr, Hentges SG. (2008c). Two-generation reproductive toxicity evaluation of dietary 17beta-estradiol (E2; CAS No. 50-28-2) in CD-1 (Swiss) mice. Toxicol Sci 102:392–412.
  • Uchida K, Suzuki A, Kobayashi K, Buchanan DL, Sato T, Watanabe H, Katsu Y, Suzuki J, Asaoka K, Mori C, Arizono K, Iguchi T. (2002). Bisphenol-A administration during pregnancy results in fetal exposure in mice and monkey. J Health Sci 48:579–582.
  • Upmeier A, Degen GH, Diel P, Michna H, Bolt HM. (2000). Toxicokinetics of bisphenol A in female DA/Han rats after single i.v. and oral administration. Arch Toxicol 74:431–436.
  • US EPA. (1984a). Ninety-day oral toxicity study in dogs. Office of Pesticides and Toxic Substances. Fiche No. OTS0509954.
  • US EPA. (1984b). Reproduction and ninety-day oral toxicity study in rats. Office of Pesticides and Toxic Substances. Fiche No. OTS0509954.
  • US EPA. (1984c). Fourteen-day range finding study in rats. Office of Pesticides and Toxic Substances. Fiche No. OTS0509954.
  • US FDA. (2010). Update on bisphenol A for use in food contact applications. Available at: http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm197739.htm, http://www.fda.gov/downloads/NewsEvents/PublicHealthFocus/UCM197778.pdf. (January 2010).
  • US FDA Memorandum. (2009a). Summary of Bisphenol A Biomonitoring Studies. Komolpraset/Twaroski, 16/11/2009.
  • US FDA Memorandum. (2009b). Bisphenol A (CAS RN. 80-05-7): Review of low dose studies. Aungst/Taroski, 08/31/2009.
  • Valle LD, Toffolo V, Nardi A, Fiore C, Bernante P, Di Liddo R, Parnigotto PP, Colombo L. (2006). Tissue-specific transcriptional initiation and activity of steroid sulfatase complementing dehydroepiandrosterone sulfate uptake and intracrine steroid activations in human adipose tissue. J Endocrinol 190:129–139.
  • Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. (2007). Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139–177.
  • Vandenberg LN, Maffini MV, Schaeberle CM, Ucci AA, Sonnenschein C, Rubin BS, Soto AM. (2008). Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice. Reprod Toxicol 26:210–219.
  • Vandenberg LN, Chauhoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. (2010a). Urinary, circulating and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 118:1055–1070.
  • Vandenberg LN, Chahoud I, Padmanabhan V, Paumgartten FJ, Schoenfelder G. (2010b). Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ Health Perspect 118:1051–1054.
  • Völkel W, Colnot T, Csanady G, Filser J, Dekant W. (2002). Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol 15:1281–1287.
  • Völkel W, Bittner N, Dekant W. (2005). Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. Drug Metabol Dispos 33:1748–1757.
  • Völkel W, Kiranoglu M, Fromme H. (2008). Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment. Toxicol Lett 179:155–162.
  • Vogel SA. (2009). The politics of plastics: The making and unmaking of bisphenol a “safety”. Am J Public Health 99 (Suppl 3):S559–S566.
  • Vom Saal FS, Myers JP. (2008). Bisphenol A and risk of metabolic disorders. JAMA 300:1353–1355.
  • Vom Saal FS, Welshons WV. (2006). Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ Res 100:50–76.
  • Waechter J Jr, Thornton C, Markham D, Domoradzki J. (2007). Factors affecting the accuracy of bisphenol A and bisphenol A-monoglucuronide estimates in mammalian tissues and urine samples. Toxicol Mech Methods 17:13–24.
  • WHO. (2005). Chemical-specific adjustment factors for interspecies differences and human variability Guidance document for use of data in dose/concentration-response assessment. Geneva: World Health Organization.
  • Willhite CC, Ball GL, McLellan CJ. (2008). Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration. J Toxicol Environ Health B Crit Rev 11:69–146.
  • Wilson NK, Chuang JC, Morgan MK, Lordo RA, Sheldon LS. (2007). An observational study of the potential exposures of preschool children to pentachlorophenol, bisphenol-A, and nonylphenol at home and daycare. Environ Res 103:9–20.
  • Yang M, Ryu JH, Jeon R, Kang D, Yoo KY. (2009). Effects of bisphenol A on breast cancer and its risk factors. Arch Toxicol 83:281–285.
  • Ye X, Kuklenyik Z, Needham LL, Calafat AM. (2005). Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 383:638–644.
  • Ye X, Bishop AM, Reidy JA, Needham LL, Calafat AM. (2007). Temporal stability of the conjugated species of bisphenol A, parabens, and other environmental phenols in human urine. J Expo Sci Environ Epidemiol 17:567–572.
  • Ye X, Wong LY, Jia LT, Needham LL, Calafat AM. (2009). Stability of the conjugated species of environmental phenols and parabens in human serum. Environ Int 35:1160–1163.
  • Zaya MJ, Hines RN, Stevens JC. (2006). Epirubicin glucuronidation and UGT2B7 developmental expression. Drug Metab Dispos 34:2097–2101.
  • Zenser TV, Lakshmi VM, Davis BB. (1999). Human and Escherichia coli beta-glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl, and their hydroxy metabolites. Drug Metab Dispos 27:1064–1067.